# ImpactLife – FDA Inspection, Sep 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/impactlife/0bbed59b-4ca9-48a4-bfb0-97f5e537af7a
Source feed: FDA_Inspections

> FDA inspection 1108056 of ImpactLife, September 18, 2019. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1108056
- Company Name: ImpactLife
- Inspection Date: 2019-09-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1293564 - 2025-11-19](https://www.keypedia.com/records/fda_inspections/impactlife/e4eba6e1-7be7-4bb4-9407-eff5cb145e84)
- FDA Inspection 1025427 - 2017-08-30
- FDA Inspection 910949 - 2015-01-22
- FDA Inspection 824712 - 2013-03-26
- FDA Inspection 718476 - 2011-04-06

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kenneth-l-smalls/7625258c-cada-4506-8daa-a64374cf9f15)

Company: https://www.keypedia.com/companies/impactlife/51b92e0c-e1d0-4cba-8e75-1510dd9ae19e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d